GaryL.DavisMD
Gastroenterology • Dallas, TXHepatology & Liver Transplantation
Professor of Medicine, Baylor College of Medicine
Are you Dr. Davis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 47 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 860
Dallas, TX 75246Phone+1 214-820-8500Fax+1 214-820-8168
Summary
- Dr. Gary Davis, MD is a gastroenterologist in Dallas, Texas. He is currently licensed to practice medicine in Texas and Florida. He is a Professor of Medicine at Baylor College of Medicine.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1979 - 1982- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1976 - 1979
University of Minnesota Medical SchoolClass of 1976
Certifications & Licensure
FL State Medical License 2015 - 2018
TX State Medical License 2002 - 2015
Publications & Presentations
PubMed
- 16 citationsTreatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trialGary L. Davis, Luis A. Balart, Eugene R. Schiff, Karen L. Lindsay, Henry C. Bodenheimer
Journal of Hepatology. 1990-01-01 - 297 citationsTolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.Henry C. Bodenheimer, K L Lindsay, G L Davis, J H Lewis, Swan N. Thung
Hepatology. 1997-08-01 - 286 citationsEstimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis CWilliam G. Bennett, Y Inoue, J R Beck, John B. Wong, Stephen G. Pauker
Annals of Internal Medicine. 1997-11-15
Press Mentions
Updated Guidance on Use of Hepatitis C DrugsJune 25th, 2015
